(NASDAQ: ALEC) Alector's forecast annual revenue growth rate of -38.56% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 113.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.93%.
Alector's revenue in 2026 is $69,048,000.On average, 10 Wall Street analysts forecast ALEC's revenue for 2026 to be $1,901,309,491, with the lowest ALEC revenue forecast at $450,795,579, and the highest ALEC revenue forecast at $3,753,500,819. On average, 8 Wall Street analysts forecast ALEC's revenue for 2027 to be $2,995,007,240, with the lowest ALEC revenue forecast at $1,283,621,311, and the highest ALEC revenue forecast at $5,008,851,899.
In 2028, ALEC is forecast to generate $1,098,063,808 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $3,146,291,180.